Creating Clarity in Metastatic Melanoma: Optimizing Treatment and Improving Outcomes
Presented by Amanda M. Viereck, PA-C, and Anthony J. Olszanski, MD, RPh
From Fox Chase Cancer Center, Temple Health, Philadelphia, Pennsylvania
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2020;11(3):280–283 |
© 2020 Harborside™
Checkpoint inhibitors and oncolytic vaccine therapy have transformed the management of metastatic melanoma. This article presents the diagnosis and treatment landscape for metastatic melanoma, including clinicopathologic features of the disease, approved and emerging therapeutics, and strategies for integrating contemporary standard-of-care management practices.
For access to the full length article, please sign in